Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) CFO Donald T. Gardner III sold 1,257 shares of the business’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now directly owns 21,358 shares in the company, valued at approximately $1,265,675.08. The trade was a 5.56 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Kewaunee Scientific Trading Down 4.4 %
Kewaunee Scientific stock traded down $2.52 during mid-day trading on Monday, hitting $55.21. The company’s stock had a trading volume of 13,280 shares, compared to its average volume of 29,773. The stock’s fifty day moving average is $48.37 and its two-hundred day moving average is $45.02. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $158.56 million, a PE ratio of 8.75 and a beta of 0.72. Kewaunee Scientific Co. has a 1 year low of $27.00 and a 1 year high of $67.20.
Hedge Funds Weigh In On Kewaunee Scientific
Several large investors have recently modified their holdings of the business. Geode Capital Management LLC raised its holdings in Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after buying an additional 1,941 shares during the period. Barclays PLC acquired a new stake in shares of Kewaunee Scientific during the third quarter valued at about $121,000. State Street Corp purchased a new stake in shares of Kewaunee Scientific in the 3rd quarter valued at approximately $266,000. Heron Bay Capital Management acquired a new position in shares of Kewaunee Scientific in the 2nd quarter worth approximately $252,000. Finally, Renaissance Technologies LLC boosted its position in shares of Kewaunee Scientific by 13.4% during the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after purchasing an additional 10,580 shares during the period. Institutional investors and hedge funds own 32.69% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Analysis on Kewaunee Scientific
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
- Five stocks we like better than Kewaunee Scientific
- With Risk Tolerance, One Size Does Not Fit All
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Delta Can Fly to New Highs in 2025; Here’s Why
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.